23andMe

November is Lung Cancer Awareness Month. Today, our CEO & Co-Founder Anne Wojcicki and her sister Janet Wojcicki sat down for a heartfelt conversation with CBS Mornings co-host Gayle King to speak about their sister Susan’s passing from lung cancer, the legacy she leaves behind, and how they plan to continue to push for more research in the space to help find ways to prevent, detect and treat this deadly disease. See their story here: https://23and.me/CBSLCA #LungCancerAwareness #LCAM #LungHealth #GeneticResearch #Advocacy #EarlyDetection #23andMe

Last week, we teamed up with Black Health Connect to host an inspiring networking event in Houston, TX. With over 1,000 healthcare professionals in attendance, the evening was filled with meaningful connections, impactful conversations, and a shared commitment to advancing health equity. We're proud to support events that bring together leaders in healthcare to foster collaboration and create opportunities to make a difference in communities nationwide. #HealthEquity #Networking #Collaboration #BlackHealthConnect

Today we announced an exciting new strategic research collaboration with Mirador Therapeutics, which will leverage 23andMe’s research database to advance Mirador’s precision medicines for immunology and inflammation! 🎉 Read more: https://23and.me/mirador

We’re looking for a Privacy Counsel II to join our Legal team! In this role, you will be responsible for providing privacy guidance across various areas of our business. Come join our Gene Pool! https://lnkd.in/gU5DBDGW

This year’s annual meeting of the American Society of Human Genetics in Denver will be massive, and among the thousands of researchers and clinicians in attendance will be a crew of scientists from 23andMe. These meetings always cover a lot but typicalLY have themes. Some of the talks, presentations, and abstracts this year will focus on health equity in genomics, using genetics for insights into cancer treatments, and strategies for using genetic discoveries for drug discovery. Check out Wednesday’s platform talk on "Genetic Approaches Informing Drug Targets and Mechanism," where Chris Eijsbouts, a 23andMe postdoctoral fellow in statistical genetics, will present our Therapeutics team's paper highlighting how using human genetic data can double or triple the success rate of drug development. Our team also has several posters exploring a range of other topics including rare variant burden testing, copy number variation and disease, and genetic variation and height. Learn more: https://23and.me/3Ae2Cpf

Last week we teamed up with the Morehouse College National Alumni Association to co-host the 2nd Annual HBCU Health and Wellness Fun Day to kickoff homecoming weekend! It was a day of energizing workouts, crucial health screenings, and an enlightening discussion featuring experts in genetics, urgent care, nutrition and fitness. Check out the video below for a recap! #healthequity #collaborations #HBCUs #wellness #longevity

We're thrilled to announce that we will be participating in the inaugural Eudēmonia Summit this weekend from Friday, November 1st - Sunday, November 3rd. Eudēmonia—named after the ancient Greek word for “well-being”— is a 3-day immersive event in West Palm Beach dedicated to helping you cultivate your personal wellness. Stop by our booth in the EXPOSŌME to say hi! Noura Abul-Husn will also be speaking about the power of personalized, preventive health on the EXPOSŌME stage on Saturday at 3:00pm, as well as be joining a panel on Sunday at 12:30pm discussing harnessing longevity in Convention Center 1F.

We’re excited to announce the launch of Records & Archives℠, the latest addition to 23andMe+ Premium. This new ancestry feature allows you to explore historical records, unlocking key details about your family’s history. By generating hints and offering access to valuable documents, Records & Archives helps provide a fuller, more accurate understanding of your ancestry. Just one of the many pluses of 23andMe+ Premium.

We're pleased to announce the addition of three new independent directors to our Board. Read more: https://lnkd.in/gbvUnZFA

23andMe researchers able to predict whether a person had Parkinson’s or not 80% of the time based on the amount and diversity of microbes in samples using Random Forest: https://23and.me/3YjERUD